Paul J. Pollock

Partner
New York
ppollock@crowell.com
Phone: +1 212.895.4216
590 Madison Avenue, 20th Floor
New York, NY 10022-2544

Paul J. Pollock is a partner in the New York office of Crowell & Moring and concentrates his practice on mergers and acquisitions and corporate finance. He provides ongoing representation to middle market private equity sponsors, family offices and their portfolio companies, as well as public and private companies that are not sponsor backed. Paul's industry experience includes representing clients in financial services, manufacturing, telecommunications, fintech, software products, publishing and entertainment, with recent emphasis on the healthcare and biotech industries.

Paul represents private equity sponsors, family offices, healthcare providers, and emerging companies in executing their acquisition objectives. He works on both the buy and sell-side of middle-market businesses seeking to realize value through the sale of their businesses, and with foreign companies who are seeking to enter the U.S. marketplace, access the U.S. securities markets or to engage in transactions with U.S. companies.

Paul has extensive experience in representing emerging companies and entrepreneurs. He works with companies through their entire life cycle including advising on the formation and choice of business entity; preparing and negotiating shareholder and limited liability company agreements, employment agreements and other critical corporate contracts; advising on multiple rounds of private equity financing and debt financing; and representing companies in their initial public offering and in connection with ongoing securities compliance filings work.

In addition to representing issuers in acquisitions and divestitures, private and public offerings and debt financings, he has also represented underwriters in public offerings and placement agents in private placements as well as foreign issuers in connection with offerings under SEC Regulations.

Responding to the Covid-19 crisis, Paul has been on the forefront of the Paycheck Protection Program under the Cares Act.  He has advised clients in determining eligibility for loans, as well as assisting clients in calculating loan and forgiveness amounts.  He has also presented on numerous webinars on the Paycheck Protection Program and was quoted in a May 13 article in The New York Times titled “Small-Business Loan Deadline Poses Test for Mnuchin.

Paul received his B.A., cum laude, from Colgate University, where he was a member of Omicron Delta Epsilon, and his J.D. from Fordham Law School. Paul is admitted to the New York bar and is a member of the New York State Bar Association, Association of the Bar of the City of New York, and the Association for Corporate Growth. Paul is also a frequent speaker and contributor at various industry conferences.

Recent Experience

Representative Healthcare Transactions

  • Representing Humana Inc. in connection with its pending acquisition of Enclara Healthcare, one of the nation’s largest hospice pharmacy and benefit management providers, from Consonance Capital Partners.
  • Representation of a Fortune 100 health insurance company in connection with its proposed acquisition of a specialty pharmacy business.
  • Representation of the US subsidiary of a Spanish-based owner of fertility clinics in connection with the proposed acquisition of a Northeast US-based In Vitro Fertilization Clinic.
  • Representation of MedLabs Holdings LLC in connection with the sale of assets to a New York-based laboratory testing company.
  • Representation of  Angion Biomedica Corp. and bicoastal based biotechnology company in connection with the sale of convertible notes.
  • Representation of Angion Biomedica Corp. in connection with the sale of Convertible Preferred Stock.
  • Representation of MedLabs Holdings LLC in connection with the acquisition of the assets of Mercy Diagnostics, Inc., a Mid-Atlantic Provider of laboratory services.
  • Representation of MedLabs Holdings LLC in connection with the proposed acquisition of a New Jersey-based provider of laboratory services.
  • Representation of Cadex Genomics Corp., a California-based developer of molecular assays used to improve care for cancer patients in connection with the sale of Convertible Notes.
  • Representation of Angion Biomedica Corp. in connection with the sale of Units consisting of Common Stock and Common Stock Purchase Warrants.
  • Representation of Caymus Capital Partners in connection with the acquisition of MedLabs Laboratory Diagnostics, Inc., a New Jersey-based laboratory.
  • Representation of DermOne Holdings LLC in connection with multiple acquisitions of dermatology and vein practices throughout the US.
  • Representation of a family office in connection with the acquisition of Accredited Dermatology, Inc.
  • Representation of a holding company in connection with the securitization and financing of pharmacy receivables.

Recent mergers and acquisitions experience includes:

  • Representation of a New York based publishing company in connection with the disposition of a subsidiary engaged in community publishing.
  • Representation of a Florida based private equity sponsor in connection with the acquisition of a Tampa, Florida based manufacturer of blinds and operator of home design centers.
  • Representation of a New York based publishing company in connection with a leveraged acquisition of Marquis Who's Who and related publications.
  • Representation of a Hong Kong based manufacturing and distribution company in connection with the acquisition of a China based manufacturer of party goods and a China based printer and manufacturer of books and specialty packaging, and related equity financing.
  • Representation of the majority owner of a Long Island based wireless technology company in connection with the company's sale to a Maryland based private equity fund.
  • Representation of a Hong Kong based company in connection with the acquisition of a New Jersey based specialty toy distributor, and related equity financing.
  • Representation of a Maryland based telecommunications company in connection with its sale by merger to a Washington, D.C., based telecommunications company.
  • Representation of a Hong Kong based toy company in connection with the acquisition out of bankruptcy of assets of a New York based toy company.
  • Representation of a Canadian based toy distribution company in connection with its merger with a Hong Kong based toy manufacturer and distributor, and related equity financing.
  • Representation of a New York based private equity sponsor in connection with the acquisition of Marquis Who's Who and related publications.
  • Representation of a Long Island based developer of software products in connection with a sale of its tax preparation software division to a Fortune 500 publishing company.

Recent corporate finance experience includes:

  • Representation of a New York based private equity sponsor in connection with a joint venture formed to acquire life insurance policies and a related subordinated debt financing.
  • Representation of a Florida based entertainment company in connection with the private sale of shares of its common stock.
  • Representation of a New York based specialty marketing firm in connection with the private offering of Class A and Class C Membership Interests.
  • Representation of a New York based private equity sponsor in connection with a joint venture formed to acquire underperforming residential mortgage loans and a related debt financing.
  • Representation of a Long Island New York software company in connection with the sale of shares of its Common Stock and Convertible Preferred Stock.
  • Representation of a Pakistan based telecommunications infrastructure company in connection with the private sale of shares of its common stock.
  • Representation of a Hong Kong based financial services oriented software company in connection with the private sale of shares of its common stock.
  • Representation of a General Partner in connection with the organization of a $600 million private equity fund formed to pursue structured finance opportunities globally.


Affiliations

  • Association of the Bar of the City of New York
  • New York State Bar Association
  • Association for Corporate Growth


Highlights, News & Knowledge


Speeches & Presentations



Publications

  • "Issues in Using Unregistered M&A Brokers in Transactions," New York Law Journal (October 31, 2016). Authors: Paul J. Pollock, Linda Lerner, and Eden L. Rohrer.


Client Alerts & Newsletters



Media Mentions



Firm News & Announcements

Dec.16.2019 DEAL NOTE: Crowell & Moring Advises Humana Inc. on Acquisition of Enclara Healthcare
Nov.26.2019 DEAL NOTE: Crowell & Moring Advises GigCapital, Inc. on Business Combination with Kaleyra S.p.A. to Form Kaleyra, Inc.
Sep.20.2019 Super Lawyers Recognizes 82 Crowell & Moring Lawyers Across United States
Nov.21.2018 DEAL NOTE: Crowell & Moring Represents Novume Solutions in Acquisition of OpenALPR
Oct.15.2018 Super Lawyers Recognizes 82 Crowell & Moring Lawyers Across United States
Jun.27.2018 Crowell & Moring Awarded The Deal’s 'Most Innovative Deal of the Year' and the Association for Corporate Growth and the M&A Advisor’s 'Deal of the Year'
Oct.31.2017 Super Lawyers Recognizes 79 Crowell & Moring Lawyers Across United States
May.23.2017 DEAL NOTE: Crowell & Moring Advises R3 in Largest Ever Investment in Distributed Ledger Technology
Feb.21.2017 DEAL NOTE: Crowell & Moring Advises UniPixel on Public Offering
Nov.21.2016 Crowell & Moring Partner Paul J. Pollock Receives Lawyers Alliance for New York 2016 Cornerstone Award for Pro Bono Service
Apr.03.2014 Deal Note: Crowell & Moring Represents Client Judith Ripka in Sale of Brand Name and IP
May.16.2011 Crowell & Moring's Corporate Group Expands on Both Coasts with Two New Partners